Delivery Order SPE2DB20D3104-SPE2DB24FV8Z4
Award Date
8/23/24
Potential Completion Date
9/16/24
Potential Value
$7.8K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is a $6,497.52 Firm Fixed Price Delivery Order for the supply of 1,500 units of the pharmaceutical product KEDRAB (1,500 Unit/10 ML Vial 10ML). The contract was awarded by the Defense Logistics Agency (DLA) Troop Support Medical, a major customer of Amerisourcebergen's federal contracting activities. Amerisourcebergen, a large pharmaceutical distributor, has been awarded numerous Indefinite Delivery...
This federal contract award to Amerisourcebergen Drug Corp is a $2,660.24 Firm Fixed Price Delivery Order from the Defense Logistics Agency (DLA) for the supply of KEDRAB 300 UNIT/2 ML VIAL 2ML medical products. The contract is not set aside and has an ultimate completion date of July 10, 2025. Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is the prime contractor for this award. The contract is associated with a larger $999,999,999.00 Indefinite Delivery Contract (IDC) between...
This federal contract award, valued at $3,248.74, was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office Division. The delivery order is for the supply of 1,500 units of the pharmaceutical product KEDRAB, a 10 ML vial, to support the agency's medical requirements. AmerisourceBergen, a major pharmaceutical distributor, has been awarded numerous federal contracts and Indefinite Delivery Contracts (IDCs) by the DLA and other agencies to provide a wide range...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order valued at $7,372.80 for the supply of KEDRAB 300 UNIT/2 ML VIAL 2ML. The contract was awarded by the Defense Logistics Agency (DLA), a defense agency, and has an ultimate completion date of December 11, 2023. Amerisourcebergen is a major pharmaceutical distributor and healthcare solutions provider that plays a critical role in supplying medical products to federal government agencies....
This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) for the delivery of KEDRAB, a 300 unit/2 ml vial medication. The $3,990.36 firm fixed price delivery order contract has a completion date of June 25, 2025 and is not set aside. AmerisourceBergen holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a wide range of...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) Troop Support Medical. The $10,083.12 firm fixed-price delivery order is for the supply of 1,500 units of the medication KEDRAB 10 ML vial. The award is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA, valued at $999,999,999 and running through November 2026. This IDC serves as the primary vehicle for...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $16,243.70 firm fixed-price delivery order is for the procurement of 1,500 units of the 10 ML KEDRAB vaccine vial. The contract has an ultimate completion date of June 20, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The award is a Delivery Order under a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2025. Under this IDC, Amerisourcebergen provides a comprehensive range of pharmaceutical products and medical supplies, including specialty, brand name, generic, and over-the-counter medications, as...
This federal contract award was granted to Amerisourcebergen Drug Corp's Corporate Office Division by the Defense Logistics Agency (DLA), a defense agency, to supply KEDRAB, a pharmaceutical product, for a ceiling value of $6,497.48. The contract is a Delivery Order with a Firm Fixed Price pricing type and an ultimate completion date of July 24, 2024. Amerisourcebergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at up to $999,999,999.00...
This federal contract award, valued at $3,248.74, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, the Corporate Office division of Amerisourcebergen Corporation. The contract is a Delivery Order for the supply of 1,500 units of the pharmaceutical product KEDRAB, a 10 ML vial. Amerisourcebergen holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the company to provide a wide range...